Double knockout of FFAR4 and FGF21 aggravates metabolic disorders in mice

Lengyun Wei1, Xianlong Ye2, Siyuan Cui3

  • 1School of Life Science, Anhui Medical University, Hefei 230032, China; Wuxi School of Medicine, Jiangnan University, Wuxi, China.

Insights

Fibroblast growth factor 21 (FGF21) signaling is crucial for metabolic health, especially when free fatty acid receptor 4 (FFAR4) is absent. Deleting both FGF21 and FFAR4 causes severe metabolic disorders, highlighting FGF21's feedback role.

Area of Science:

  • Metabolic disorders
  • Endocrinology
  • Molecular biology

Background:

  • Free fatty acid receptor 4 (FFAR4) involvement in metabolic disorders is debated.
  • Endogenous fibroblast growth factor 21 (FGF21) signaling's role in FFAR4-deficient mice requires clarification.

Purpose of the Study:

  • To investigate the role of endogenous FGF21 signaling in FFAR4-deficient mice.
  • To determine the impact of FFAR4 and FGF21 double deficiency on metabolic status.

Main Methods:

  • Generation of FFAR4/FGF21 double knockout (DKO) mice.
  • Evaluation of glucose and lipid metabolism in FFAR4 KO mice on a high-fat diet.

Main Results:

  • FGF21 levels were significantly elevated in FFAR4-deficient mice.
  • Double deletion of FGF21 and FFAR4 resulted in severe metabolic disorders.
  • FFAR4/FGF21 DKO mice exhibited metabolic abnormalities linked to reduced energy expenditure.

Conclusions:

  • Endogenous FGF21 acts as a master feedback regulator in the absence of FFAR4.
  • FFAR4 deficiency influences FGF21 levels and metabolic regulation.